Navigation Links
Internal Fixation Systems Announces 510(k) Approval Granted by FDA for Subtalar Implants

MIAMI, Jan. 23, 2012 /PRNewswire/ -- (OTC: IFIX) Internal Fixation Systems today announced that it has received 510(k) clearance from the FDA to market subtalar implants. These implants are used to preserve motion at the ankle joint and to treat both trauma conditions and arthritis.  IFS CEO, Stephen Dresnick, MD, stated that, "this approval allows us to continue to fill out our portfolio, and gives us another product for surgeons who use our products." IFS currently offers a full line of mini-cannulated screws for small bone fixation as well as a Modular Locking Small Fragment System for treatment of bone fractures and osteotomies. 

About IFS:  Internal Fixation Systems, Inc is a manufacturer and marketer of high quality, responsibly priced orthopedic and podiatric implants.
We seek to prove that superior products and lower costs can go hand in hand.   IFS focuses on widely used, market proven products used to treat common fractures.  Our Advisory Panel, consisting of nationally recognized surgeons, provides input on how to improve our implant designs.  The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition.  IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons.  Please contact us for more information about our product and business model.
This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events.  Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of Internal Fixation, such as whether we sell our new product offering  There are numerous risks and uncertainties that could cause actual results and Internal Fixation's plans and objectives to differ materially from those expressed in the forward-looking information, including whether Internal Fixation will have sufficient capital to continue its operations..  Actual results and future events could differ materially from those anticipated in such information.  These and all subsequent written and oral forward-looking information are based on estimates and views of  management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, IFS does not intend to update these forward-looking statements.For further information, please contact:

Laura Cattabriga, Chief Financial Officer


Tel: 786 268 0995



SOURCE Internal Fixation Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. JCM Passes Internal Quality Assessment for Azithromycin API Production
2. Internal and External Communication Insights: Effective Approaches for Reaching Clients and Co-Workers
3. Internal Fixation Systems, Inc. Announces Sale of Modular Locking Small Fragment System
4. Internal Fixation Systems, Inc. Announces DTC Eligibility
5. Internal Fixation Systems, Inc. Receives FDA 510(k) Clearance to Market Fixation Devices to Treat Bone Fractures and Osteotomies
6. Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function
7. Building Support for a New Product Through Effective Internal Disease State Communication
8. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
9. Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB
10. Maximizing the Potential of Internal and External Communications Groups
11. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):